Mainstream

Castle Biosciences raises 2025 revenue guidance to $310M–$320M following strong Q2 execution and test volume growth

Castle Biosciences raises 2025 revenue guidance to $310M–$320M following strong Q2 execution and test volume growth

Post ContentcstlRead More

You might also be interested in reading Blockchain-friendly Wyoming challenges Delaware’s biz incorporation dominance.

August 5, 2025
In Mainstream